Home/Filings/4/0001209191-20-004725
4//SEC Filing

Bagattini Roy 4

Accession 0001209191-20-004725

CIK 0000094845other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 6:36 PM ET

Size

32.3 KB

Accession

0001209191-20-004725

Insider Transaction Report

Form 4
Period: 2020-01-21
Bagattini Roy
EVP & President, Americas
Transactions
  • Disposition to Issuer

    Class B Common Stock

    2020-01-21$20.00/sh4,997$99,9403,133 total
    Class A Common Stock (4,997 underlying)
  • Sale

    Class A Common Stock

    2020-01-23$20.02/sh51,737$1,035,54279,420 total
  • Exercise/Conversion

    Class B Common Stock

    2020-01-21$7.42/sh+8,130$60,3658,130 total
    Class A Common Stock (8,130 underlying)
  • Conversion

    Class A Common Stock

    2020-01-22+54,037133,457 total
  • Sale

    Class A Common Stock

    2020-01-22$20.00/sh2,300$46,001131,157 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2020-01-218,1300 total
    Exercise: $7.42Exp: 2022-02-04Class B Common Stock (8,130 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    2020-01-2141,870285,640 total
    Exercise: $6.10Exp: 2023-02-09Class B Common Stock (41,870 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2020-01-21$6.85/sh+75,000$513,75096,973 total
    Class A Common Stock (75,000 underlying)
  • Disposition to Issuer

    Class B Common Stock

    2020-01-21$20.00/sh42,936$858,72054,037 total
    Class A Common Stock (42,936 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2020-01-21$6.10/sh+41,870$255,40745,003 total
    Class A Common Stock (41,870 underlying)
  • Disposition to Issuer

    Class B Common Stock

    2020-01-21$20.00/sh23,030$460,60021,973 total
    Class A Common Stock (23,030 underlying)
  • Conversion

    Class B Common Stock

    2020-01-2254,0370 total
    Class A Common Stock (54,037 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    2020-01-2175,000769,480 total
    Exercise: $6.85Exp: 2023-07-13Class B Common Stock (75,000 underlying)
Footnotes (8)
  • [F1]The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan.
  • [F2]Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person.
  • [F3]Price represents the weighted average sale price of the shares sold. The sale price ranged from $20.00 to $20.01 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F4]Price represents the weighted average sale price of the shares sold. The sale price ranged from $20.00 to $20.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F5]100% of these SARs are fully vested.
  • [F6]Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
  • [F7]Of these SARs: (i) 229,830 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable; and (ii) 55,810 are time-based SARs from an original grant of 275,800 SARs, of which 219,990 have been exercised, that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.
  • [F8]Of these SARs: (i) 544,820 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable, of which 75,000 have been exercised; and (ii) 299,660 from an original grant of 653,790 SARs, of which 354,130 have been exercised, are time-based SARs that vested as to 25% of the SARs on July 13, 2017, with the remainder vesting in 36 equal monthly installments thereafter.

Issuer

LEVI STRAUSS & CO

CIK 0000094845

Entity typeother

Related Parties

1
  • filerCIK 0001768720

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:36 PM ET
Size
32.3 KB